HBM Healthcare Investments

The strategic build-up of positions usually begins with privately held companies that have growth potential, and is expanded through subsequent financing rounds and, where applicable, an IPO.

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

The page says healthcare is a major, fast-growing economic sector, driven by demographic trends, medical advances, rising prosperity and improved access to medical products and services. It also notes a strong need for new treatment options.

Typically, building a strategic position begins by investing in a private company with development potential and expands at follow-on financing rounds as well as IPOs.

HBM Healthcare Investments reported a 9.8% rise in NAV per share to CHF 297.30 and a 7.8% dividend-adjusted share price increase to CHF 233.50 in the first half of 2026/2027; it expects a half-year profit of about CHF 177 million.

The individual has over 30 years in life sciences and private equity, including roles at Deutsche Venture Capital (DVC), Deutsche Bank and LION Bioscience AG. They hold an MBA from ASTON Business School and MSc and PhD degrees in chemistry.

The individual has over 30 years in life sciences and private equity, including roles at Deutsche Venture Capital (DVC), Deutsche Bank and LION Bioscience AG. They are a board member of Swixx Healthcare.

The individual has over 20 years in finance, including investment banking and private wealth management at UBS, and several years covering compliance at Schroder Investment Management (Switzerland). They hold a Bachelor of Science ZFH in Business Administration from HWZ.

The individual has over 20 years of financial industry experience, including investment banking and private wealth management at UBS, and has overseen compliance at Schroder Investment Management (Switzerland) AG.

HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. The company holds and manages an international portfolio of promising companies.

HBM Healthcare Investments invests in the healthcare sector. The company holds and manages an international portfolio of promising companies in human medicine, biotechnology, medical technology and diagnostics, as well as related fields.

Over the past five years, the net asset value (NAV) per share and share price of HBM Healthcare Investments (HBMN) have delivered attractive returns. The distribution yield was between 3 and 5 percent per year over the same period.

HBM Healthcare Investments Ltd. is located at Bundesplatz 1, CH-6300 Zug, Switzerland.

HBM Healthcare Investments AG Bundesplatz 1 6300 Zug Switzerland

Listed on SIX Swiss Exchange (HBMN), HBM Healthcare Investments is a Swiss investment company holding a well-balanced globally diversified portfolio of investments in private and public healthcare companies.